The neurobiology of drug addiction

World Health Organization, 1990, International Statistical Classification of Diseases and Related Health Problems, 10th revision

American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, 4

Institute of Medicine, 1996, Pathways of Addiction

10.1007/BF02244907

White FJ, 1991, The Biological Bases of Drug Tolerance and Dependence, 153

10.1016/1044-5765(92)90012-Q

10.1097/00008877-199308000-00003

10.1126/science.2903550

10.1001/archpsyc.1973.01750350005001

10.1016/S1044-5765(05)80043-0

Nestler EJ, Fitzgerald LW, Self DW: Substance abuse: neurobiology, in The American Psychiatric Press Review of Psychiatry, vol 14, edited by Oldham JM, Riba MB. Washington, DC,American Psychiatric Press, 1995, pp51-81

Tabakoff B, 1992, Substance Abuse: A Comprehensive Textbook, 152

10.1037/h0058775

Stein L, 1836, Psychopharmacology: A Review of Progress (1957-1967) (US Public Health Service publ no, 105

Nauta WJH, 1969, Charles C Thomas, 136

Liebman JL, 1989, Cooper SJ: The Neuropharmacological Basis of Reward

10.1152/ajplegacy.1966.210.2.270

10.1016/0165-6147(92)90060-J

10.1126/science.1948035

10.1038/354066a0

10.1016/0014-5793(91)81406-X

10.1016/0005-2728(93)90109-S

O'Callaghan JP, 1994, J Pharmacol Exp Ther, 270, 741

Angrist B, 1976, Handbook of Psychopharmacology, vol 11, 99

10.1016/0091-3057(83)90261-7

10.1016/B978-0-08-017922-3.50175-1

Spealman RD, 1977, J Pharmacol Exp Ther, 202, 500

10.1016/0006-8993(81)90177-3

Kornetsky C, 1979, Federation Proceedings, 38, 2473

10.1016/0006-8993(82)91123-4

Carr GD, Fibiger HC, Phillips AG: Conditioned place preference as a measure of drug reward, in The Neuropharmacological Basis of Reward, edited by Liebman JM, Cooper SJ. New York,Oxford University Press, 1989, pp264-319

Koob GF, 1987, Oreland L, 35

10.1016/0006-8993(75)90233-4

10.1016/0014-2999(76)90352-6

10.1007/BF00421062

10.1126/science.1114313

10.1007/BF00428151

10.1097/00008877-199506000-00004

10.1016/0304-3940(87)90451-4

10.1016/0091-3057(89)90019-1

10.1097/00008877-199000140-00009

10.1126/science.8099761

10.1016/0091-3057(80)90166-5

10.1016/0091-3057(79)90040-6

10.1901/jeab.1994.61-213

10.1146/annurev.pa.09.040169.002411

10.1007/BF00405254

Koob GF, 1984, J Pharmacol Exp Ther, 229, 481

Goldberg SR, 1971, J Pharmacol Exp Ther, 176, 464

10.1016/S0090-6980(76)80003-2

10.1016/0091-3057(85)90027-9

Negus SS, 1993, J Pharmacol Exp Ther, 265, 1245

10.1016/0006-8993(83)91232-5

10.1007/BF00431681

10.1016/0304-3940(91)90678-M

10.1016/0091-3057(84)90284-3

10.1007/BF00427441

10.1111/j.1749-6632.1992.tb25972.x

West TE: The effects of nucleus accumbens injections of receptorselective opiate agonists on brain stimulation reward. Doctoral dissertation,Concordia University, Montreal, Quebec, Canada,1991

10.1038/265645a0

Di Chiara G, 1988, J Pharmacol Exp Ther, 244, 1067

Hemby SE, 1995, J Pharmacol Exp Ther, 273, 591

10.1016/0024-3205(81)90148-X

10.1016/0165-6147(92)90062-B

10.1016/0006-3223(89)90052-8

10.1007/BF00427827

10.1111/j.1749-6632.1992.tb25980.x

10.1007/978-1-4684-3189-6_6

10.1016/1044-5765(91)90016-H

10.1126/science.3022383

Koob CF., 1996, The Pharmacology of Alcohol and Alcohol Dependence, 477, 10.1093/oso/9780195100945.003.0013

Frye GD, Breese CR: GABAergic modulation of ethanol-induced motor impairment. I Pharmacol Exp Ther 1982; 223:750-756

10.1007/BF00470592

10.1016/0091-3057(87)90357-1

10.1111/j.1530-0277.1993.tb00736.x

Fitzgerald LW, 1995, Clin Neurosci, 3, 165

10.1111/j.1471-4159.1989.tb07280.x

10.1126/science.2467382

10.1176/ajp.152.3.332

10.1016/0091-3057(88)90167-0

Weiss F, 1993, J Pharmacol Exp Ther, 267, 250

10.1016/0006-8993(93)90004-7

EngeIj A, 1992, Novel Pharmacological Interventions for Alcoholism, 68

Sellars EM, 1992, Pharmacol Sd, 13, 69

10.1038/clpt.1990.62

10.1016/0741-8329(91)90573-F

10.1016/0091-3057(93)90527-Z

10.1001/archpsyc.1992.01820110045007

10.1001/archpsyc.1992.01820110040006

10.1007/BF02244930

10.1007/BF02244770

10.1007/BF02245149

10.1016/0306-4522(88)90217-5

Johnston JB, Further contributions to the study of the evolution of the forebrain.) Comp Neurol 1923

10.1007/978-1-4757-0145-6_1

10.1016/0306-4522(91)90202-Y

10.1016/0006-8993(95)00598-K

Pontieri FE, 1995, Di Chiara C: Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell

10.1016/0014-2999(95)00314-B

Heyser CJ, 1995, Society for Neuroscience Abstracts, 21, 1698

10.1523/JNEUROSCI.15-08-05439.1995

10.1038/276186a0

Taylor JR, Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology (Berl) 1988

Maldonado R, Role of different brain structures in the expression of the physical morphine withdrawal syndrome.) Pharmacol Exp Ther 1992

10.1016/0014-2999(90)90022-X

10.1111/j.1749-6632.1992.tb25978.x

10.1001/archpsyc.1986.01800020013003

10.1001/archpsyc.1990.01810210069010

10.1016/0091-3057(78)90082-5

10.1016/0091-3057(80)90242-7

10.1016/0024-3205(86)90501-1

10.1016/0091-3057(88)90199-2

10.1016/0091-3057(86)90121-8

Schulteis C, Decreased brain reward produced by ethanol withdrawal. Proc NatI Acad Sci USA 1995

Hubner CB, 1992, Pharmacol Exp Ther, 260, 562

10.1016/0091-3057(92)90223-3

Bauco P, 1994, J Pharmacol Exp Ther, 271, 294

10.1007/978-1-4757-1305-3_9

10.1073/pnas.92.13.5880

10.1007/BF00421544

Parsons LH, Koob CF. Weiss F: Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.) Pharmacol Exp Iher 1995; 274:1182-1191

Markou A, 1991, Neuropsychopharmacology, 4, 17

10.1016/0031-9384(92)90211-J

Legault M, 1994, Society for Neuroscience Abstracts, 20, 1032

10.1016/S0896-6273(00)80109-9

10.1016/0165-0173(93)90013-P

10.1037/h0036128

10.1037/h0077058

10.1037/0033-295X.98.3.390

10.1016/0006-8993(92)91327-B

10.1016/0306-4522(90)90106-E

10.1111/j.1530-0277.1996.tb01125.x

Weiss F, Parsons LH, Schulteis C, etal: Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats.) Neurosci 1996; 16:3474-3485

Collins AC, 1990, The Biology of Nicotine Dependence, 87

10.1016/S0896-6273(00)80112-9

10.1006/smns.1994.1029

10.1146/annurev.pa.36.040196.002043

Henry, 1991, J Pharmacol Exp Ther, 258, 882

10.1016/0006-8993(93)91364-X

Rasmussen K, Beitner-Johnson DB, Krystal JH, etal: Opiate withdrawal and rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates.) Neurosci 1990; 10:2308-2317

10.1016/0166-2236(92)90171-4

10.1016/S0140-6736(78)92823-4

10.1523/JNEUROSCI.12-07-02439.1992

10.1016/0896-6273(93)90213-B

10.1038/283625a0

10.1016/S0896-6273(00)80110-5

Sharma SK, Nirenberg M: Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc NatI Acad Sci USA 1975

10.1523/JNEUROSCI.13-08-03525.1993

Widnell KL, 1994, Russell D

10.1126/science.273.5275.657

10.1016/0006-8993(89)91466-2

Akaoka H, Aston-Jones C: Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory add input.) Neurosd 1991; 11:3830-3839

10.1146/annurev.ne.18.030195.002335

10.1038/npp.1994.37

10.1016/0896-6273(94)90061-2

10.1016/S0896-6273(00)80111-7

Widnell K, 1996, J Pharmacol Exp Ther, 276, 306

10.1007/BF02245336

Young AM, 1995, Kupfer DJ, 733

10.1126/science.1824728

Kovoor A, Chavkin C: Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).) Blot Chem 1995

Koob CF, 1995, Kupfer DJ, 759

10.1007/BF00432175

10.1007/978-1-4612-4812-5_12

O'Brien CP, 1995, New York, 1745

10.1001/archpsyc.1996.01830080023006

10.1016/0024-3205(86)90601-6

10.1126/science.271.5255.1586